Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Feasibility Assessment of Facilitated Subcutaneous Immunoglobulin 1.0 G/Kg with Abbreviated Dose Ramp-Up and without Ramp-Up: A Phase 1 Tolerability and Safety Study in Healthy Adults

              Author:Li, Zhaoyang   Nagy, Andras   Khaskhely, Noor   Lindner, Dirk   Duff, Kimberly   Garcia, Enrique   Ay, Hakan   Rondon, Juan Carlos   Yel, Leman   

              Session Name:P6: General Neurology: New Treatments  

              Topic:General Neurology  

              Program Number:P6.003  

              Author Institution:Takeda Development Center Americas, Cambridge, MA  Clinical Pharmacology of Miami, LLC, an ERG Portfolio Company, Miami, FL